Serial Number | 86622937 |
Word Mark | IMAGINE WHERE WE CAN GO |
Filing Date | Thursday, May 7, 2015 |
Status | 710 - CANCELLED - SECTION 8 |
Status Date | Friday, September 20, 2024 |
Registration Number | 5418590 |
Registration Date | Tuesday, March 6, 2018 |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, March 22, 2016 |
Goods and Services | Education, namely, developing, arranging and conducting educational seminars, workshops and programs and providing courses of instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; provision of educational content, namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; providing computer, electronic and online databases featuring information about medical education in the field of healthcare, medicine, medical treatment and patient care; training in the use and operation of pharmaceutical products, pharmaceutical preparations, radiopharmaceutical preparations, medical devices, medical imaging apparatus and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, lectures, panel discussions, and training programs in the fields of healthcare, the use of pharmaceutical and medical devices, medical research, surgery, medical science, medicine and medical diseases, disorders and related treatments; Educational services, namely, providing non-downloadable webinars in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; educational services, namely, conducting live and online seminars, classes, workshops, lectures, panel discussions and training in the field of health; educational services, namely, providing non-downloadable webinars in the field of health; education services, namely, conducting online and telephonic instruction and courses in the fields of health and medical issues |
Goods and Services | Pharmaceutical, medicinal preparations and substances, namely, vaccines, antitoxic sera, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations and substances for the treatment of thrombosis, embolisms, inflammation, and autoimmune disease; pharmaceutical and medicinal preparations and substances, namely, vaccines and vaccine adjuvants, proteins, peptides, sera containing polyclonal antibodies and fragments thereof and polyclonal antibodies and fragments derived therefrom all for use in treating overdose of toxic substances, and sepsis; drug delivery agents, namely, preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolisation; pharmaceutical preparations and substances for embolisation of tumours and arteriovenous malformations (AVMs); pharmaceutical preparations and substances for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medicinal purposes, vaccine adjuvants and vaccine preparations containing adjuvant; pharmaceutical preparations for the treatment of digoxin, digitalis and other cardio-active glycoside toxicity; chemical reagents for medical and veterinary therapeutic and diagnostic purposes; chemico-pharmaceutical preparations for use in the treatment of digoxin, digitalis and other cardio-active glycoside toxicity; chemical preparations for medical and pharmaceutical purposes and medicines for use in the treatment of digoxin, digitalis and other cardio-active glycoside toxicity; transarterial chemoembolisation pharmaceutical preparations, vaccines and sera; pharmaceutical preparations in the form of foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams and for use in preparing foams, for sclerotherapy, phlebology, angiology and proctology, namely, for the treatment of oesophageal varices, hydroceles, in sterilisation treatment and for treatment of varicose veins, and arterio-venous malformations; pharmaceutical preparations containing methotrexate antidotes; pharmaceutical preparations containing 5-fluorouracil antidotes; pharmaceutical preparations for use in chemotherapy and for the treatment of autoimmune diseases; pharmaceutical preparations used for regulating toxicity levels of therapeutic agents; pharmaceutical preparations used for depleting concentrations of therapeutic agents |
Goods and Services | Provision of medical and surgical information; provision of medical and surgical information on-line from a computer database or from the Internet or by telecommunication means; services for the provision of medical information; providing medical information; providing a website featuring information regarding medicine, medical treatment, patient care, prescription drugs, ordering, prescribing, and dispensing practices of drugs, treatment and aftercare; providing a website featuring medical information regarding medicine, medical treatment, patient care, prescription drugs, ordering, prescribing, and dispensing practices of drugs, treatment and aftercare; medical services, namely, diagnosis, assessment, treatment and aftercare in the fields of sclerotherapy, phlebology, angiology, proctology, interventional oncology, ablation of tumours using embolic beads, ablation of tumours using embolic drug eluting beads, and in connection with varicose veins, arterio-venous malformations; medical analysis for the diagnosis and treatment of persons; pharmacy advice; pharmacy advice, namely, medical advice on pharmaceuticals; advisory services relating to health and healthcare; advisory services relating to medicine and medical treatment and services; medical advisory services relating to patient care; conducting health assessment surveys, health risk assessment surveys, treatment outcome surveys and health advice and information services; health care consultancy services; consultancy services relating to medical treatment; information services relating to health care and medical treatment; providing health and medical information via hotline services enabling medical, counselling, and nursing personnel access to records to enable assistance with patient coverage, reimbursement, ordering, and site-of-care support questions; provision of medical records by hotline services; healthcare consultancy services, namely, providing a hotline for medical, counselling and nursing personnel; healthcare consultancy services, namely, providing patient and patient medical record information by hotline services; providing health and medical information by hotline services; advisory services relating to health and healthcare; advisory services relating to medicine and medical treatment and services; medical advisory services relating to patient care; healthcare consultancy services; consultancy services relating to medical treatment; information services relating to healthcare and medical treatment; advisory services relating to medical apparatus, instruments and preparations; medical advisory services relating to medical apparatus, instruments and preparations; advisory services relating to medical services; preparation of medical reports; advisory, consultancy and information services relating to the aforesaid services |
Goods and Services | Surgical and medical apparatus and instruments, namely, medical syringes, surgical and medical apparatus for producing and administering pharmaceutical foams, surgical and medical apparatus for producing foams for treatment of varicose veins, arterio-venous malformations, oesophageal varices and hydroceles, devices for intravenous administration of pharmaceutical foam, and diagnostic devices for grading the severity of venous conditions, and toxic drugs overdose; surgical, medical and veterinary apparatus and instruments, namely, medical device, apparatus and instruments for treating cancer; drug delivery embolisation apparatus, instruments and systems; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials; medical apparatus and instruments for embolisation; surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatus, instruments and systems comprising surgical and medical instruments for embolization, namely, embolic devices for use in treating cancer and tumors, embolic devices for treating arteriovenous malformations (AVMs) of the body, and embolic devices for use in treating tumors; drug delivery embolisation systems; drug delivery apparatus and instruments, namely, a drug delivery system comprised of injection syringes and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; medical apparatus and instruments for embolization, namely, medical devices in the nature of particles, namely, embolic microspheres for embolization; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; surgical and medical apparatus for producing and administering foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering sclerosing foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering foams for use in sclerotherapy, phlebology, angiology and proctology; surgical and medical apparatus for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices and hycroceles; medical devices for intravenous administration of sclerosing foam for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; medical devices for monitoring the position and effect of sclerosing foam in the human body for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; medical diagnostic apparatus for diagnosing all the above medical conditions, namely, varicose veins, arterio-venous malformations, oesophageal varices, spider veins hydroceles, cancer, tumors, and circulatory system conditions and pulmonary and thoracic conditions; compression bandages; component parts and fittings for all of the aforesaid goods |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, September 20, 2024 |
Primary Code | 005 |
First Use Anywhere Date | Wednesday, December 23, 2015 |
First Use In Commerce Date | Wednesday, December 23, 2015 |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, September 20, 2024 |
Primary Code | 010 |
First Use Anywhere Date | Wednesday, December 23, 2015 |
First Use In Commerce Date | Wednesday, December 23, 2015 |
International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
US Class Codes | 100, 101, 107 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, September 20, 2024 |
Primary Code | 041 |
First Use Anywhere Date | Thursday, November 3, 2016 |
First Use In Commerce Date | Thursday, November 3, 2016 |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, September 20, 2024 |
Primary Code | 044 |
First Use Anywhere Date | Tuesday, January 20, 2015 |
First Use In Commerce Date | Tuesday, January 20, 2015 |
Party Name | BTG International Limited |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | London EC4M7RD GB |
Party Name | BTG International Limited |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | London EC4M7RD GB |
Party Name | BTG International Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | London EC4M7RD GB |
Event Date | Event Description |
Monday, May 11, 2015 | NEW APPLICATION ENTERED |
Saturday, May 16, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, June 11, 2015 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Friday, June 19, 2015 | ASSIGNED TO LIE |
Tuesday, June 30, 2015 | ASSIGNED TO LIE |
Tuesday, July 7, 2015 | ASSIGNED TO LIE |
Wednesday, July 8, 2015 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
Tuesday, July 28, 2015 | ASSIGNED TO EXAMINER |
Tuesday, August 4, 2015 | NON-FINAL ACTION WRITTEN |
Tuesday, August 4, 2015 | NON-FINAL ACTION E-MAILED |
Tuesday, August 4, 2015 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, February 3, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, February 3, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, February 4, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, February 5, 2016 | EXAMINERS AMENDMENT -WRITTEN |
Friday, February 5, 2016 | EXAMINERS AMENDMENT E-MAILED |
Friday, February 12, 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Friday, February 5, 2016 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Friday, February 5, 2016 | EXAMINER'S AMENDMENT ENTERED |
Friday, February 5, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, March 2, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, March 22, 2016 | PUBLISHED FOR OPPOSITION |
Tuesday, March 22, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, May 17, 2016 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Wednesday, September 14, 2016 | SOU TEAS EXTENSION RECEIVED |
Wednesday, September 14, 2016 | SOU EXTENSION 1 FILED |
Wednesday, September 14, 2016 | SOU EXTENSION 1 GRANTED |
Friday, September 16, 2016 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, May 3, 2017 | SOU TEAS EXTENSION RECEIVED |
Wednesday, May 3, 2017 | SOU EXTENSION 2 FILED |
Wednesday, May 3, 2017 | SOU EXTENSION 2 GRANTED |
Friday, May 5, 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Thursday, November 16, 2017 | TEAS STATEMENT OF USE RECEIVED |
Thursday, November 16, 2017 | USE AMENDMENT FILED |
Thursday, November 30, 2017 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Tuesday, January 30, 2018 | STATEMENT OF USE PROCESSING COMPLETE |
Wednesday, January 31, 2018 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Thursday, February 1, 2018 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Tuesday, February 20, 2018 | ASSIGNED TO EXAMINER |
Tuesday, March 6, 2018 | REGISTERED-PRINCIPAL REGISTER |
Saturday, August 29, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Saturday, August 29, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Saturday, August 29, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Saturday, August 29, 2020 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
Saturday, August 29, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Saturday, August 29, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Monday, August 30, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Monday, August 30, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Monday, August 30, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Monday, August 30, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Monday, August 30, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Monday, March 6, 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
Thursday, March 16, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Thursday, March 16, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Thursday, March 16, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, March 16, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, March 16, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Thursday, July 20, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Thursday, July 20, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, July 20, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Friday, September 20, 2024 | CANCELLED SEC. 8 (6-YR) |